An assessment of oxidized LDL in the lipid profiles of patients with obstructive sleep apnea and its association with both hypertension and dyslipidemia, and the impact of treatment with CPAP

Atherosclerosis

Volumn 241, Issue 2, 2015, Pages 342-349

  Feres, Marcia C ^a   Fonseca, Francisco A H ^a   Cintra, Fatima D ^a   Mello Fujita, Luciane ^a,b   de Souza, Altay Lino ^a   De Martino, Maria C ^c   Tufik, Sergio ^a,b,c,d   Poyares, Dalva ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Instituto Florestal de São Paulo   (Brazil)

^c AFIP   (Brazil)

^d Associaçao Fundo de Incentivo à Pesquisa AFIP ^*  (Brazil)

Author keywords

Atherogenesis; Lipid peroxidation; Obstructive sleep apnea; Oxidative modifications; Oxidized LDL

Indexed keywords

CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; UREA; ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER; LOW DENSITY LIPOPROTEIN;

ADULT; ARTERIAL PRESSURE; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OXYGEN SATURATION; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING; SLEEP PARAMETERS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; BLOOD; BLOOD PRESSURE; BRAZIL; COMORBIDITY; DRUG EFFECTS; DYSLIPIDEMIAS; MIDDLE AGED; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SLEEP APNEA, OBSTRUCTIVE; TIME FACTOR; TREATMENT OUTCOME; UPREGULATION;

ADULT; ANTIHYPERTENSIVE AGENTS; BIOMARKERS; BLOOD PRESSURE; BRAZIL; COMORBIDITY; CONTINUOUS POSITIVE AIRWAY PRESSURE; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATIVE STRESS; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 84930965906     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.05.008     Document Type: Article

References (36)

1. Xie A., Skatrud J.B., Puleo D.S., Morgan A.B.J. Exposure to hypoxia produces long-lasting sympathetic activation in humans. J.Appl. Physiol. 2001, 98:1555-1562.
2. Savransky V., Nanayakkara A., Li J., Bevans S., Smith P.L., Rodriguez A., et al. Chronic intermittent hypoxia induces atherosclerosis. Am. J. Respir. Crit. Care Med. 2007, 175(12):1290-1297.
3. Cintra F., Tufik S., Paola A., Feres M.C., Mello-Fujita L., Oliveira W., Rizzi C., Poyares D. Cardiovascular profile in patients with obstructive sleep apnea. Arq. Bras. Cardiol. 2011, 96:293-299.
4. Svantikova A., Worlk R., Lerman L.O., Juncos L.A., Greene E.L., McConnell J.P., Somers V.K. Oxidative stress in obstructive sleep apnoea. Eur. Heart J. 2005, 26:2435-2439.
5. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J.Biol. Chem. 1997, 272:20963-20966.
6. Witztum J.L., Steinberg D. Role of oxididized low density proteins in atherogenesis. J.Clin. Invest 1991, 88:1785-1792.
7. Libby P. Vascular biology of atherosclerosis: overview state of the art. Am. J. Cardiol. 2003, 91:3-6.
8. Libby P. Inflammation in atherosclerosis. Nature 2002, 420(6917):868-874.
9. Matsuura E., Hughes G.R., khamashta M.A. Oxidation of LDL and its clinical implication. Autoimmun 2008, 7:558-566.
10. Drager L.F., Bortolotto L.A., Figueiredo A.C., Krieger E.M., Lorenzi G.F. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 2007, 176:706-712.
11. Kryger M.H., Wali S.O., Bahammam A.S., Massaeli H., Pierce G.N., Iliskovic N., Singal P.K. Susceptibility of LDL to oxidative stress in obstructive sleep apnea. Sleep 1998, 21:290-296.
12. Prabhakar N.R. Obstructive sleep apnea: a oxidative stress?. Am. J. Respir. Crit. Care Med. 2002, 165:859-860.
13. Lavie L., Vishnevsky A., Lavie P. Evidence for lipid perxidation in obstructive sleep apnea. Sleep 2004, 27:123-128.
14. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine Task Force. Sleep 1999, 22:667-689.
15. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al. National heart, lung, and blood institute joint national committee on prevention, detection, evaluation, and treatment of high blood pressure; national high blood pressure education program coordinating committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003, 289:2560-2572. Erratum in: JAMA. 2003;290:197.
16. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001, 285:2486-2497.
17. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003, 42:1206-1252.
18. Standardization of spirometry, 1994 update. American thoracic society. Am. J. Respir. Crit. Care Med. 1995, 152:1107-1136.
19. EEG arousals: scoring rules and examples: a preliminary report from Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992, 15:173-184.
20. Rechtschaffen A., Kales A. AManual of Standardized Terminology, Technique and Scoring System for Sleep Stages of Human Sleep 1968, Los Angeles Brain Information Service, Brain Information Institute, Los Angeles, CA.
21. Holvoet P., Mertens A., Verhamme P., Bogaerts K., Beyens G., Verhaeghe R., Collen D., Muls E., Van de Werf F. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arter. Thromb. Vasc. Biol. 2001, 21:844-848.
22. National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) 2001, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung and Blood Institute, Bethesda (MD).
23. Saarelainen S., Lehtimaki T., JaaK-Kola O., Poussa T., Nikkila M., Solakivi T., Nieminen M.M. Autoantibodies against oxidized low-density lipoprotein in patients with obstructive sleep apnoea. Clin. Chem. Lab. Med. 1999, 37:517-520.
24. Atkeson A., yeh S.Y., Mahotra A., Jelic S. Endothelial function in obstructive sleep apnea. Prog. Cardiovasc Dis. 2009, 51:351-362.
25. Kobayashi K., Kishi M., Atsumi T., Bertolaccini M.L., Makino H., Sakari N., Yamamoto I., Yasuda T., Khamasshita M.A., Hughes G.R.V., Koike T., Voelker D.R., Matsuura E. Circurlating oxidized LDL forms complexes with B2-glycoprotein I: implication as an atherogenic autoantigen. J.Lipid Res. 2003, 44:716-726.
26. Arnaud C., Dematteis M., pepin J.L., Baguet J.P., levy P. Obstructive sleep apnea. Immuno-inflammation and atherosclerosis. Semin. Immunopathol. 2009, 31910:113-125.
27. Godoy J., Meliado P., Tapia J., Santin J. Obstructive sleep apnea as na independent stroke risk factor: possible mechanisms. Curr. Mol. Med. 2009, 9:203-209.
28. Itabe H., Obama T., Kato R. The dynamics of oxidized LDL during atherogenesis. J.Lipids 2011, 2011:418313.
29. Konstantino Y., Wolk R., Terra S.G., Nguyen T.T., Fryburg D.A. Non-traditional biomarkers of atherosclerosis in stable and unstable coronary artery disease, do they differ. Acute Card. Care 2007, 9:197-206.
30. González J., Valls N., Brito R., Rodrigo R. Essential hypertension and oxidative stress: new insights. World J. Cardiol. 2014;26, 6(6):353-366.
31. Matsuura E., Kobayashi K., Tabuchi M., Lpez L.R. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis. Prog. Lipid Res. 2008, 45:466-486.
32. Jelic S., Le Jemtel T.H. Inflammation. oxidative stress and the vascular endothelium in obstructive sleep apnea. Trends Cardiovasc Med. 2008, 18:253-260.
33. Lorenz M.W., Markus H.S., Bots M.L., Rosvall M., Sitzee M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007, 115(4):459-467.
34. Nadeen R., Singh M., Nida M., Kwon S., Sajid H., Witkowski J., Pahomov E., Shah K., Park W., Champeau D. Effect of CPAP treatment for obstructive sleep apnea hypopnea syndrome on lipid profile: a meta-regression analysis. J.Clin. Sleep. Med. 2014, 10(12):1295-1302.
35. Darkova Z., Petrasova D., Molcanyiva A., Popovnakova M., Tkacova R. Effects of contínuos positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest 2008, 134:686-692.
36. Xu H., Yi H., Guan J., Yin S. Effect of continuous positive airway pressure on lipid profile in patients with obstructive sleep apnea syndrome. A meta-analysis of randomized controlled trials. Atherosclerosis 2014, 234:446-453. 20.